![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » ART SUBMITS LICENCE APPLICATION TO HEALTH CANADA TO BEGIN COMMERCIALIZATION OF ITS SOFTSCAN BREAST IMAGING DEVICE
ART SUBMITS LICENCE APPLICATION TO HEALTH CANADA TO BEGIN COMMERCIALIZATION OF ITS SOFTSCAN BREAST IMAGING DEVICE
June 22, 2006
ART Advanced Research Technologies Inc., a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that it has filed a Medical Device Licence Application with Health Canada to begin the commercialization of its SoftScan breast imaging
device. The granting of a licence will allow ART to distribute the SoftScan device
in Canada by certifying that the device is safe and effective and meets quality
standards.
CCN
Matthews
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct